Neuromuscular blockade management in the critically Ill patient
Open Access
- 24 May 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Intensive Care
- Vol. 8 (1), 1-15
- https://doi.org/10.1186/s40560-020-00455-2
Abstract
Neuromuscular blocking agents (NMBAs) can be an effective modality to address challenges that arise daily in the intensive care unit (ICU). These medications are often used to optimize mechanical ventilation, facilitate endotracheal intubation, stop overt shivering during therapeutic hypothermia following cardiac arrest, and may have a role in the management of life-threatening conditions such as elevated intracranial pressure and status asthmaticus (when deep sedation fails or is not tolerated). However, current NMBA use has decreased during the last decade due to concerns of potential adverse effects such as venous thrombosis, patient awareness during paralysis, development of critical illness myopathy, autonomic interactions, and even residual paralysis following cessation of NMBA use. It is therefore essential for clinicians to be familiar with evidence-based practices regarding appropriate NMBA use in order to select appropriate indications for their use and avoid complications. We believe that selecting the right NMBA, administering concomitant sedation and analgesic therapy, and using appropriate monitoring techniques mitigate these risks for critically ill patients. Therefore, we review the indications of NMBA use in the critical care setting and discuss the most appropriate use of NMBAs in the intensive care setting based on their structure, mechanism of action, side effects, and recognized clinical indications. Lastly, we highlight the available pharmacologic antagonists, strategies for sedation, newer neuromuscular monitoring techniques, and potential complications related to the use of NMBAs in the ICU setting.Keywords
This publication has 121 references indexed in Scilit:
- Practice Guidelines for Management of the Difficult AirwayAnesthesiology, 2013
- A fresh look at paralytics in the critically ill: real promise and real concernAnnals of Intensive Care, 2012
- Reduction in deep vein thrombosis incidence in intensive care after a clinician education programJournal of Thrombosis and Haemostasis, 2010
- Residual Neuromuscular Blockade and Critical Respiratory Events in the Postanesthesia Care UnitAnesthesia & Analgesia, 2008
- Advances in Neurobiology of the Neuromuscular JunctionAnesthesiology, 2002
- Neuromuscular Blockade in the Intensive Care UnitSeminars in Respiratory and Critical Care Medicine, 2001
- Postextubation laryngeal edema in adults risk factor evaluation and prevention by hydrocortisoneIntensive Care Medicine, 1996
- Critical illness myopathy and neuropathyThe Lancet, 1996
- Temporal correlation of succinylcholine-induced fasciculations to loss of twitch response at different stimulating frequenciesJournal of Clinical Anesthesia, 1992
- Tactile and Visual Evaluation of the Response to Train-of-four Nerve StimulationAnesthesiology, 1985